FIELD: medicine; pharmacology.
SUBSTANCE: declared invention refers to medicine and pharmacology, and represents a method of treating cerebral stroke caused by middle cerebral artery occlusion, comprising administering to a patient a composition containing transferrin, wherein transferrin is a mixture of apotransferrin and holotransferrin in ratio of 98 % apotransferrin : 2 % of holotransferrin, and wherein apopreffrin is administered in amount of 385 mg/kg.
EFFECT: using the declared invention is effective for treating cerebral stroke caused by middle cerebral artery occlusion.
5 cl, 14 dwg, 1 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND COMPOSITIONS FOR STABILISATION OF HYPOXIA INDUCED FACTOR-2 ALPHA AS METHOD OF CANCER MEDICAL TREATMENT | 2012 |
|
RU2602498C2 |
| APPLICATION OF STABILISERS OF HIF- ALPHA FOR INTENSIFICATION OF ERYTHROPOIESIS | 2004 |
|
RU2414214C2 |
| AGENT, ACTIVATING TRANSCRIPTION FACTOR HIF | 2015 |
|
RU2602306C2 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
| CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS | 2014 |
|
RU2557385C1 |
| ANTISENSE OLIGONUCLEOTIDES TO HIF-1-ALPHA | 2017 |
|
RU2753517C2 |
| PROLYL HYDROXYLASE INHIBITORS | 2010 |
|
RU2518071C2 |
| MODULATION OF TUMOR RESISTANCE BY PROTEIN-MEDIATED O DELIVERY | 2016 |
|
RU2731450C2 |
| LACTOFERRIN AND NEURONAL HEALTH AND DEVELOPING INTESTINE IN INFANTS | 2010 |
|
RU2552328C2 |
| FAT CONTENT CONTROL | 2003 |
|
RU2346688C2 |
